Tumour microenvironment-responsive nanoplatform based on biodegradable liposome-coated hollow MnO₂ for synergistically enhanced chemotherapy and photodynamic therapy

References

• Hu TT, Wang ZD, Shen WC, et al. Recent advances in innovative strategies for enhanced cancer photodynamic therapy. Theranostics. 2021;11(7):3278–3300.
   PubMed Web of Science ®Google Scholar
• Yang HY, Liu RF, Xu YX, et al. Photosensitizer nanoparticles boost photodynamic therapy for pancreatic cancer treatment. Nanomicro Lett. 2021;13(1):35.
   PubMed Web of Science ®Google Scholar
• Liang GF, Wang HJ, Shi H, et al. Recent progress in the development of upconversion nanomaterials in bioimaging and disease treatment. J Nanobiotechnol. 2020;18(1):154.
   PubMed Web of Science ®Google Scholar
• Liu ZY, Xie ZJ, Li WT, et al. Photodynamic immunotherapy of cancers based on nanotechnology: recent advances and future challenges. J Nanobiotechnol. 2021;19(1):160.
   PubMed Web of Science ®Google Scholar
• Bhattarai P, Hameed S, Dai ZF. Recent advances in anti-angiogenic nanomedicines for cancer therapy. Nanoscale. 2018;10(12):5393–5423.
   PubMed Web of Science ®Google Scholar
• Thakkar S, Sharma D, Kalia K, et al. Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: a review. Acta Biomater. 2020;101:43–68.
   PubMed Web of Science ®Google Scholar
• Li Y, Lin JY, Wang PY, et al. Tumor microenvironment cascade-responsive nanodrug with self-targeting activation and ROS regeneration for synergistic oxidation-chemotherapy. Nanomicro Lett. 2020;12(1):182.
   PubMed Web of Science ®Google Scholar
• Cheng HL, Wang XY, Liu X, et al. An effective NIR laser/tumor-microenvironment co-responsive cancer theranostic nanoplatform with multi-modal imaging and therapies. Nanoscale. 2021;13(24):10816–10828.
   PubMed Web of Science ®Google Scholar
• Sun YX, Zhao DY, Wang G, et al. Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development. Acta Pharm Sin B. 2020;10(8):1382–1396.
   PubMed Web of Science ®Google Scholar
• Li XS, Kwon N, Guo T, et al. Innovative strategies for hypoxic-tumor photodynamic therapy. Angew Chem Int Ed Engl. 2018;57(36):11522–11531.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yang Z, He WS, et al. One-pot synthesis of a self-reinforcing cascade bioreactor for combined photodynamic/chemodynamic/starvation therapy. J Colloid Interface Sci. 2021;599:543–555.
   PubMed Web of Science ®Google Scholar
• Zhong H, Huang PY, Yan P, et al. Versatile nanodrugs containing glutathione and heme oxygenase 1 inhibitors enable suppression of antioxidant defense system in a two-pronged manner for enhanced photodynamic therapy. Adv Healthc Mater. 2021;10(19):e2100770.
   PubMed Web of Science ®Google Scholar
• Duan HX, Liu YH, Gao ZG, et al. Recent advances in drug delivery systems for targeting cancer stem cells. Acta Pharm Sin B. 2021;11(1):55–70.
   PubMed Web of Science ®Google Scholar
• Kabakov AE, Yakimova AO. Hypoxia-induced cancer cell responses driving radioresistance of hypoxic tumors: approaches to targeting and radiosensitizing. Cancers. 2021;13(5):1102.
   PubMed Web of Science ®Google Scholar
• Xiong QX, Liu BY, Ding MX, et al. Hypoxia and cancer related pathology. Cancer Lett. 2020;486:1–7.
   PubMed Web of Science ®Google Scholar
• Rohwer N, Cramer T. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways. Drug Resist Updat. 2011;14(3):191–201.
   PubMed Web of Science ®Google Scholar
• de Heer EC, Jalving M, Harris AL. HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer. J Clin Invest. 2020;130(10):5074–5087.
   PubMed Web of Science ®Google Scholar
• Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene. 2010;29(5):625–634.
   PubMed Web of Science ®Google Scholar
• Kim Y, Nam HJ, Lee J, et al. Methylation-dependent regulation of HIF-1α stability restricts retinal and tumour angiogenesis. Nat Commun. 2016;7:10347.
   PubMed Web of Science ®Google Scholar
• Cheng X, He L, Xu J, et al. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy. Acta Biomater. 2020;112:234–249.
   PubMed Web of Science ®Google Scholar
• Xu L, Zhang ZC, Ding YW, et al. Bifunctional liposomes reduce the chemotherapy resistance of doxorubicin induced by reactive oxygen species. Biomater Sci. 2019;7(11):4782–4789.
   PubMed Web of Science ®Google Scholar
• Meng LT, Gan SJ, Zhou Y, et al. Oxygen-rich chemotherapy via modified abraxane to inhibit the growth and metastasis of triple-negative breast cancer. Biomater Sci. 2018;7(1):168–177.
   PubMed Web of Science ®Google Scholar
• Li S, Yang SP, Liu C, et al. Enhanced photothermal-photodynamic therapy by indocyanine green and curcumin-loaded layered MoS2 hollow spheres via inhibition of P-glycoprotein. IJN. 2021;16:433–442.
   Google Scholar
• Baglo Y, Liang BJ, Robey RW, et al. Porphyrin-lipid assemblies and nanovesicles overcome ABC transporter-mediated photodynamic therapy resistance in cancer cells. Cancer Lett. 2019;457:110–118.
   PubMed Web of Science ®Google Scholar
• Robinson K, Tiriveedhi V. Perplexing role of P-glycoprotein in tumor microenvironment. Front Oncol. 2020;10:265.
   PubMed Web of Science ®Google Scholar
• Jaakkola P, Mole DR, Tian YM, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001;292(5516):468–472.
   PubMed Web of Science ®Google Scholar
• Semenza GL. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci. 2012;33(4):207–214.
   PubMed Web of Science ®Google Scholar
• Lee K, Zhang HF, Qian DZ, et al. Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization. Proc Natl Acad Sci USA. 2009;106(42):17910–17915.
   PubMed Web of Science ®Google Scholar
• Zhang XJ, He CC, Liu XG, et al. One-pot synthesis of a microporous organosilica-coated cisplatin nanoplatform for HIF-1-targeted combination cancer therapy. Theranostics. 2020;10(7):2918–2929.
   PubMed Web of Science ®Google Scholar
• Hassan S, Laryea D, Mahteme H, et al. Novel activity of acriflavine against colorectal cancer tumor cells. Cancer Sci. 2011;102(12):2206–2213.
   PubMed Web of Science ®Google Scholar
• Marti-Diaz R, Montenegro MF, Cabezas-Herrera J, et al. Acriflavine, a potent inhibitor of HIF-1alpha, disturbs glucose metabolism and suppresses ATF4-protective pathways in melanoma under non-hypoxic conditions. Cancers. 2020;13(1):102.
   Web of Science ®Google Scholar
• Mangraviti A, Raghavan T, Volpin F, et al. HIF-1α-targeting acriflavine provides long term survival and radiological tumor response in brain cancer therapy. Sci Rep. 2017;7(1):14978.
   PubMedGoogle Scholar
• Wong CC, Zhang HF, Gilkes DM, et al. Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis. J Mol Med. 2012;90(7):803–815.
   PubMed Web of Science ®Google Scholar
• Lequeux A, Noman MZ, Xiao M, et al. Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy. Oncogene. 2021;40(28):4725–4735.
   PubMed Web of Science ®Google Scholar
• Dana S, Prusty D, Dhayal D, et al. Potent antimalarial activity of acriflavine in vitro and in vivo. ACS Chem Biol. 2014;9(10):2366–2373.
   PubMed Web of Science ®Google Scholar
• Ya W, Sc M, Cb X, et al. Advances in aggregatable nanoparticles for tumor-targeted drug delivery. Chin Chem Lett. 2020;31:1366–1374.
   Web of Science ®Google Scholar
• Huang H, Mao L, Li Z, et al. Multifunctional polypyrrole-silver coated layered double hydroxides embedded into a biodegradable polymer matrix for enhanced antibacterial and gas barrier properties. J Bioresourc Bioproducts. 2019;4:231–241.
   Google Scholar
• Liu YL, Yang JX, Liu B, et al. Human iPS cells loaded with MnO2-based nanoprobes for photodynamic and simultaneous enhanced immunotherapy against cancer. Nanomicro Lett. 2020;12(1):127.
   PubMed Web of Science ®Google Scholar
• Cai XX, Zhu QX, Zeng Y, et al. Manganese oxide nanoparticles as MRI contrast agents in tumor multimodal imaging and therapy. Int J Nanomedicine. 2019;14:8321–8344.
   PubMed Web of Science ®Google Scholar
• Yang GB, Ji JS, Liu Z. Multifunctional MnO2 nanoparticles for tumor microenvironment modulation and cancer therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021;13(6):e1720.
   PubMed Web of Science ®Google Scholar
• Yuan ZT, Fan GH, Wu HL, et al. Photodynamic therapy synergize with PD-L1 checkpoint blockade for immunotherapy of colorectal cancer by multifunctional nanoparticle. Mol Ther. 2021;29(10):2931–2948.
   PubMed Web of Science ®Google Scholar
• Lu Y, Li LH, Lin ZF, et al. Enhancing osteosarcoma killing and CT imaging using ultrahigh drug loading and NIR-responsive bismuth sulfide@mesoporous silica nanoparticles. Adv Healthc Mater. 2018;7(19):e1800602.
   PubMed Web of Science ®Google Scholar
• Wang RN, Han Y, Sun B, et al. Deep tumor penetrating bioparticulates inspired burst intracellular drug release for precision chemo-phototherapy. Small. 2018;14(12):e1703110.
   PubMed Web of Science ®Google Scholar
• Juriga D, Nagy K, Jedlovszky-Hajdu A, et al. Biodegradation and osteosarcoma cell cultivation on poly(aspartic acid) based hydrogels. ACS Appl Mater Interfaces. 2016;8(36):23463–23476.
   PubMed Web of Science ®Google Scholar
• Zhang YH, Zhao RB, Liu J, et al. Hierarchical nano-to-molecular disassembly of boron dipyrromethene nanoparticles for enhanced tumor penetration and activatable photodynamic therapy. Biomaterials. 2021;275:120945.
   PubMed Web of Science ®Google Scholar
• Yang GB, Xu LG, Chao Y, et al. Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses. Nat Commun. 2017;8(1):902.
   PubMedGoogle Scholar
• Fei WD, Zhang Y, Han SP, et al. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma. Int J Pharm. 2017;519(1–2):250–262.
   PubMed Web of Science ®Google Scholar
• Igarashi S, Hattori Y, Maitani Y. Biosurfactant MEL-A enhances cellular association and gene transfection by cationic liposome. J Control Release. 2006;112(3):362–368.
   PubMed Web of Science ®Google Scholar
• Wang L, Niu XX, Song QL, et al. A two-step precise targeting nanoplatform for tumor therapy via the alkyl radicals activated by the microenvironment of organelles. J Control Release. 2020;318:197–209.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Ji YH. Nanostructured manganese dioxide for anticancer applications: preparation, diagnosis, and therapy. Nanoscale. 2020;12(35):17982–18003.
   PubMed Web of Science ®Google Scholar
• Lin LS, Song JB, Song L, et al. Simultaneous fenton-like ion delivery and glutathione depletion by MnO2-based nanoagent to enhance chemodynamic therapy. Angew Chem Int Ed Engl. 2018;57(18):4902–4906.
   PubMed Web of Science ®Google Scholar
• Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 1991;51(3):794–798.
   PubMed Web of Science ®Google Scholar
• Yang XX, Al Hegy A, Gauthier ER, et al. Influence of mixed organosilane coatings with variable RGD surface densities on the adhesion and proliferation of human osteosarcoma Saos-2 cells to magnesium alloy AZ31. Bioact Mater. 2017;2(1):35–43.
   PubMed Web of Science ®Google Scholar
• Fang ZH, Sun YP, Xiao H, et al. Targeted osteosarcoma chemotherapy using RGD peptide-installed doxorubicin-loaded biodegradable polymeric micelle. Biomed Pharmacother. 2017;85:160–168.
   PubMed Web of Science ®Google Scholar
• Chang R, Sun L, Webster TJ. Selective inhibition of MG-63 osteosarcoma cell proliferation induced by curcumin-loaded self-assembled arginine-rich-RGD nanospheres. Int J Nanomedicine. 2015;10:3351–3365.
   PubMed Web of Science ®Google Scholar
• Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12(12):931–947.
   PubMed Web of Science ®Google Scholar